Preovulatory Treatment of Mice with Anti-VEGF Receptor 2 Antibody Inhibits Angiogenesis in Corpora Lutea
- 31 July 2001
- journal article
- Published by Elsevier in Microvascular Research
- Vol. 62 (1) , 15-25
- https://doi.org/10.1006/mvre.2001.2312
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Role of vascular endothelial growth factor in ovarian physiology and pathologyFertility and Sterility, 2000
- Mechanisms of angiogenesis and arteriogenesisNature Medicine, 2000
- Suppression of Luteal Angiogenesis in the Primate after Neutralization of Vascular Endothelial Growth Factor1Endocrinology, 2000
- Multiple Developmental Roles of VEGF Suggested by a LacZ-Tagged AlleleDevelopmental Biology, 1999
- Vascular endothelial growth factor is essential for corpus luteum angiogenesisNature Medicine, 1998
- Expression of the angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in the ovary.Journal of Animal Science, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization.Proceedings of the National Academy of Sciences, 1995